Valneva wants short-term travel, too, for JE vaccine Ixiaro
This article was originally published in Scrip
Executive Summary
While a US federal panel last week unanimously backed the use of Valneva's Ixiaro in youngsters and adolescents to protect against Japanese encephalitis (JE), which can be deadly, the committee's recommendation was limited, with the experts declaring the vaccine need not be considered for short-term travelers whose visits will be restricted to urban areas of countries in which the mosquito-borne flavivirus is endemic or times outside of a well-defined transmission season.